Enrichment Program

In-silico identification of novel prognostic gene biomarker in Breast Cancer (BRCA)

---

The worldwide impact of breast cancer (BRCA) has received a lot of attention due to its poor prognosis which leads to the high mortality and morbidity rate. Studies suggest that the high morbidity rate is mainly due to ineffectiveness of existing conventional therapies including chemotherapy, surgery as well as radiation therapy. Consequently, researchers are investigating gene therapy as a promising treatment for BRCA. An effective gene therapy involves the prognostic gene biomarkers associated with BRCA. Despite all of the identified prognosis biomarkers of BRCA, reports indicate that the current prognostic gene biomarker is ineffective and does not meet the requirements of clinical procedures. Therefore, it is essential to explore novel prognostic biomarkers associated with the poor prognosis of BRCA. These explorations involve in-silico studies through the data mining process utilizing various bioinformatics tools to analyze gene expression, prognostic value, correlation analysis and enrichment pathways analysis. Several analyses have identified the overexpression of gene Y in tumor samples and its association with the poor prognosis of BRCA. Moreover, it has been identified that gene Y also contributes to cell cycle regulation through enrichment pathway analysis.

---

Availability

Detail Information

Series Title

-

Call Number

EP BM-025

Publisher

i3L, Jakarta : i3L, Jakarta., 2024

Collation

-

Language

English

ISBN/ISSN

-

Classification

EP BM-025

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Data mining
BRCA
gene Y
In-silico
gene biomarker

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment